Johnson & Johnson (JNJ) stock is trading lower even after the company raised its 2026 sales forecast.
Defiance ETFs chief investment officer Sylvia Jablonski and Yahoo Finance's Julie Hyman discuss the importance of AI for Johnson & Johnson, pharmaceuticals, and biotech.
source & further reading
ca.finance.yahoo.com — original article
Why AI could be a game ghanger for housing
Warsh says AI could turbocharge the economy. The Fed is keeping close watch.
AI lobbying gains new foothold with Nvidia PAC ahead of midterm elections